This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (313) Clinical Cancer Research (88) Cancer and Clinical Trials (20) Cancer Self-Management (55) Colon and Rectal Cancer (22) Health Services Research in Oncology (36) Complementary and Alternative Medicine (35)

Published on in Vol 11, No 5 (2022): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34292, first published .
Effect of the Nutraceutical Micodigest 2.0 on the Complication Rate of Colorectal Cancer Surgery With Curative Intent: Protocol for a Placebo-Controlled Double-blind Randomized Clinical Trial

Effect of the Nutraceutical Micodigest 2.0 on the Complication Rate of Colorectal Cancer Surgery With Curative Intent: Protocol for a Placebo-Controlled Double-blind Randomized Clinical Trial

Effect of the Nutraceutical Micodigest 2.0 on the Complication Rate of Colorectal Cancer Surgery With Curative Intent: Protocol for a Placebo-Controlled Double-blind Randomized Clinical Trial

Authors of this article:

Cristina Regueiro1 Author Orcid Image ;   Laura Codesido1 Author Orcid Image ;   Laura García-Nimo2 Author Orcid Image ;   Sara Zarraquiños1 Author Orcid Image ;   David Remedios1 Author Orcid Image ;   Arturo Rodríguez-Blanco3 Author Orcid Image ;   Esteban Sinde3 Author Orcid Image ;   Catalina Fernández-de-Ana3 Author Orcid Image ;   Joaquín Cubiella1 Author Orcid Image
Article Authors Cited by Tweetations (9) Metrics

Cristina Regueiro   1 , PhD ;   Laura Codesido   1 , MSc ;   Laura García-Nimo   2 , MD ;   Sara Zarraquiños   1 , MD ;   David Remedios   1 , MD ;   Arturo Rodríguez-Blanco   3 , PhD ;   Esteban Sinde   3 , PhD ;   Catalina Fernández-de-Ana   3 , PhD ;   Joaquín Cubiella   1 , MD, PhD

1 Department of Gastroenterology, Complexo Hospitalario Universitario de Ourense, Instituto de Investigación Sanitaria Galicia Sur, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Ourense, Spain

2 Clinical Analysis Department, Complexo Hospitalario Universitario de Ourense, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Ourense, Spain

3 Hifas da Terra SL, Pontevedra, Spain

Corresponding Author:

  • Cristina Regueiro, PhD
  • Department of Gastroenterology, Complexo Hospitalario Universitario de Ourense
  • Instituto de Investigación Sanitaria Galicia Sur
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
  • Ramón Puga 52-54
  • Ourense, 32002
  • Spain
  • Phone: 34 988385824
  • Email: cristinaregueiroexposito@gmail.com